⚠ Evidence warning: Clinical trials or other evidence do not support the claim that a dandelion spring cleanse, a bitter aperitif or a dandelion-plus-milk-thistle regimen detoxifies the liver, lowers liver enzymes, restores the cephalic phase of digestion and brings noticeable improvement in digestion, weight loss and skin, or that bitter-poor modern diets cause an epidemic of functional dyspepsia. This page keeps it as a report of what people, websites or other media say.

Dandelion for Liver and Detoxification

Liver and Detox — scientific infographic poster

Dandelion root has been used as a "liver herb" continuously for over a thousand years across European, Arabic, and Chinese medical traditions. The German Commission E — Germany's regulatory body for herbal medicines, comparable in rigor to the U.S. Food and Drug Administration (FDA) — formally approved dandelion root preparations for "disorders of bile flow, loss of appetite, and dyspepsia" in 1985 after evaluating the available controlled data and the long traditional record. The mechanism is now reasonably well-mapped: bitter sesquiterpene lactones trigger a vagal reflex that stimulates bile release (cholagogue effect), triterpenes and polyphenols directly stimulate hepatic bile production (choleretic effect), and the same polyphenols protect hepatocytes from oxidative damage in chemical-injury models. This deep-dive walks through the mechanism, the regulatory record, the integrative pairing with milk thistle that anchors modern liver-support protocols, and the traditional European spring-cleanse practice.


Table of Contents

  1. Dandelion as the Original "Liver Herb"
  2. The German Commission E Approved Indication
  3. Cholagogue vs Choleretic — Two Bile-Flow Mechanisms
  4. The Bitter-Mediated Vagal Reflex
  5. Hepatoprotection in Chemical-Injury Models
  6. Phase II Detoxification and Glutathione Recycling
  7. The Traditional European Spring Liver Cleanse
  8. The Milk Thistle Pairing for Fatty Liver
  9. Fatty Liver Disease (MASLD) and Chronic Mild Transaminase Elevation
  10. Dosage, Forms, and Preparation
  11. Cautions and Drug Interactions
  12. Key Research Papers
  13. Connections
  14. Featured Videos

Dandelion as the Original "Liver Herb"

Across at least four major medical traditions — the Hippocratic, Galenic, Arabic-Galenic, and Traditional Chinese — dandelion has been consistently classified as a liver-supporting plant. The convergence is striking. The Arabian physician Ibn Sina (Avicenna), writing in The Canon of Medicine in the early 11th century, described dandelion's use for jaundice, gallbladder stagnation, and "diseases of the liver." Hildegard von Bingen, the 12th-century German Benedictine abbess and herbalist, prescribed dandelion for what she termed "yellow bile" stagnation. Traditional Chinese Medicine knows the plant as pū gōng yīng (literally "puffball herb") and assigns it the function of "clearing heat and damp" from the liver and gallbladder meridians, applied clinically for jaundice, hepatitis, and mastitis.

The phenomenon is unlikely to be coincidence across geographically separated traditions. The cholagogue effect — bile flow visibly increases after consumption — would have been clinically observable to ancient and medieval physicians, particularly in patients with biliary stasis where increased bile flow would produce relief from postprandial heaviness, yellow stools turning the normal brown, and improvement in jaundice severity. The pattern matches the modern mechanism: dandelion stimulates bile flow, bile flow improves fat digestion and excretion of conjugated bilirubin, and the clinical syndromes of biliary stagnation improve in tandem.

In modern integrative medicine, dandelion has retained its status as a foundational liver herb, used both alone and in combination with milk thistle, burdock, schisandra, and turmeric in the most common commercial "liver support" formulations. The continuity from Avicenna and Hildegard through modern herbalism is unusually unbroken for a botanical — some herbs fade from use, others come into fashion, but dandelion as a liver herb has been continuously prescribed for over a thousand years.

Back to Table of Contents

The German Commission E Approved Indication

Germany has the most developed regulatory framework in the Western world for herbal medicines. From 1978 to 1994, the German Federal Health Office's Commission E reviewed and published monographs on approximately 380 herbal substances, evaluating both clinical evidence and the traditional record. The Commission E monographs remain the most authoritative scientific source for traditional Western herbal medicine, and have been translated to English and widely referenced by integrative practitioners outside Germany.

The Commission E approved dandelion root (Taraxaci radix) for the following indications:

The Commission E approved dandelion herb (Taraxaci herba, the leaf with stem) for similar indications but with greater emphasis on the diuretic effect. The approved daily dose for dandelion root is 3-4 g of dried root for infusion, or 4-10 mL of fluid extract (1:1).

The European Medicines Agency (EMA) Committee on Herbal Medicinal Products (HMPC) subsequently issued its own monograph — the agency's page lists it as first published in January 2011 and last updated in April 2020, with a periodic review that opened a new call for scientific data in March 2026 — classifying dandelion root with herb as a "Traditional Herbal Medicinal Product" with approved indications for "increase amount of urine to achieve flushing of the urinary tract as an adjuvant in minor urinary complaints" and "to relieve symptoms related to mild digestive disorders such as feeling of abdominal fullness, flatulence and slow digestion." The European Medicines Agency monograph reflects a more conservative regulatory standard than the German Commission E but converges on the same general therapeutic profile.

The practical upshot is that dandelion is one of the few herbs with formal regulatory endorsement in major Western pharmacopeias for hepatobiliary indications. This is not merely traditional or folk medicine — it is a regulated herbal medicinal product with defined therapeutic claims supported by a structured evaluation process.

Back to Table of Contents

Cholagogue vs Choleretic — Two Bile-Flow Mechanisms

The pharmacology vocabulary distinguishes two distinct mechanisms by which an agent can increase bile flow:

Most plant bitter agents are both cholagogue and choleretic to varying degrees. Dandelion root extract has been shown to have substantial cholagogue activity (bitter reflex mediated through the vagus nerve and cholecystokinin/CCK release) and modest but measurable choleretic activity (direct hepatic stimulation by triterpene and polyphenol constituents).

The cholagogue mechanism is straightforward: the bitter taste of dandelion on the tongue activates type 2 taste receptors (TAS2Rs), which signal through the chorda tympani branch of the facial nerve to the brainstem nucleus of the solitary tract. The brainstem responds with efferent vagal signals to the digestive tract, including release of cholecystokinin from intestinal I cells when the food bolus enters the duodenum. CCK is the master gallbladder-contraction hormone; it triggers gallbladder smooth-muscle contraction and simultaneous relaxation of the sphincter of Oddi, allowing concentrated bile to flow into the duodenum.

The choleretic mechanism is less fully mapped but appears to involve direct hepatocyte stimulation by dandelion root triterpenes (taraxasterol, taraxerol, beta-amyrin, lupeol). These constituents have been shown in isolated-perfused-liver experiments to increase hepatic bile output independently of any vagal signal, suggesting a direct effect on hepatocyte bile-acid synthesis or bile-acid transport across the canalicular membrane.

Back to Table of Contents

The Bitter-Mediated Vagal Reflex

The bitter reflex deserves separate discussion because it is the same mechanism that drives dandelion's digestive-aid effect and many of its other therapeutic actions. The reflex is ancient — bitter taste perception evolved in vertebrates as a mechanism to detect potentially toxic plant alkaloids, and the same neural circuit was repurposed to trigger upstream digestive preparation when food is about to enter the gut.

The taraxacin and lactucin sesquiterpene lactones in dandelion bind to multiple TAS2R bitter taste receptors on the tongue. The signal propagates through the facial nerve (chorda tympani for the anterior two-thirds of the tongue, glossopharyngeal for the posterior third) to the nucleus of the solitary tract in the medulla. The brainstem then activates parasympathetic efferent output to the upper digestive tract via the vagus nerve, producing:

  1. Salivation — from the parotid, submandibular, and sublingual glands, with both volume and bicarbonate content increased
  2. Gastric acid secretion — from the parietal cells of the stomach, mediated by acetylcholine release at the parietal cell M3 muscarinic receptor
  3. Pancreatic enzyme secretion — including amylase, lipase, and the proteases (trypsinogen, chymotrypsinogen) released as zymogens for activation in the duodenum
  4. Gallbladder contraction and bile release — via the CCK pathway discussed above
  5. Increased gastric motility and stomach emptying

This entire cascade is referred to as the "cephalic phase" of digestion — the phase that precedes any actual food entry into the gut, prepared by neural anticipation rather than by direct contact of food with digestive tissue. The cephalic phase accounts for roughly 30% of total digestive secretion in a healthy meal. Modern diets that lack bitterness (the typical American diet has been progressively bitter-stripped through plant breeding for sweetness and bitterness-suppressing food technology) blunt the cephalic phase, contributing to the modern epidemic of functional dyspepsia, postprandial bloating, and the "I just don't feel like eating" anorexia of stress and depression.

A small bitter aperitif before meals — a few drops of dandelion tincture in water, a small wedge of grapefruit, a small glass of bitter aperitif wine, or several fresh dandelion leaves in a pre-meal salad — restores the cephalic-phase trigger and produces noticeable improvement in digestion. This is one of the most reproducible and immediately apparent benefits of dandelion in clinical use.

Back to Table of Contents

Hepatoprotection in Chemical-Injury Models

The standard preclinical model for testing hepatoprotective agents is the carbon tetrachloride (CCl4) intoxication model in rodents. CCl4 is metabolized by cytochrome P450 2E1 (CYP2E1) in hepatocytes to the highly reactive trichloromethyl radical, which initiates lipid peroxidation chain reactions that damage cell membranes and ultimately cause hepatocyte necrosis. Pretreatment or co-treatment with hepatoprotective agents can be assessed by measuring serum transaminase elevation (alanine aminotransferase (ALT), aspartate aminotransferase (AST)), histologic damage, and oxidative-stress markers.

Dandelion root extract has demonstrated significant hepatoprotection against CCl4-induced liver injury in multiple rodent studies. In one of them (Mahesh and colleagues, 2010) the animals were mice, and the materials tested were an ethanol extract of the root and a fraction concentrated in its sesquiterpene lactones — not a root tea. Given after the carbon tetrachloride, both lowered the liver enzymes ALT and AST, alkaline phosphatase and bilirubin, and reduced the liver damage seen under the microscope. The mechanism appears to involve:

Similar hepatoprotection has been demonstrated against ethanol-induced liver injury, acetaminophen (paracetamol) overdose, lipopolysaccharide (LPS) inflammatory liver injury, and various other chemical hepatotoxins. The pattern is consistent: dandelion root extract reduces transaminase elevation, preserves hepatocyte structure on histology, and maintains the antioxidant defense system. The magnitude of effect is generally modest compared to the gold-standard hepatoprotective extract silymarin from milk thistle, but is reproducible across multiple laboratories and toxin models.

Translation from animal models to human clinical effect is incomplete. There are no large-scale randomized controlled trials of dandelion extract for human liver disease, and no published human trial of dandelion alone on liver enzymes or fatty liver was found. The animal-model data, together with the centuries of traditional use and the German Commission E indication, are the basis for current integrative practice. The evidence is suggestive and mechanistically plausible, but not definitive for any specific human liver condition.

Back to Table of Contents

Phase II Detoxification and Glutathione Recycling

The liver's biotransformation of toxins is conventionally divided into two phases. Phase I (mostly cytochrome P450 enzymes) introduces or unmasks a reactive functional group on the substrate, often producing a more reactive intermediate. Phase II (conjugation reactions: glucuronidation, sulfation, glutathione conjugation, methylation, acetylation, amino acid conjugation) attaches a water-soluble moiety to the Phase I product, allowing excretion via bile or urine.

The bottleneck is often Phase II. A diet or supplement regimen that upregulates Phase I without parallel Phase II support can transiently produce more toxic intermediates than the cell can conjugate, with paradoxical worsening of oxidative damage. This is one reason naive "detox cleanses" can sometimes produce symptomatic worsening before improvement.

Dandelion appears to selectively upregulate Phase II detoxification, particularly glutathione synthesis and glutathione-S-transferase (GST) activity. The mechanism involves Nrf2 (nuclear factor erythroid 2-related factor 2), the master transcription factor for the cell's antioxidant defense and Phase II detoxification gene battery. Dandelion polyphenols, especially chicoric acid and luteolin, have been shown to disrupt the binding of Nrf2 to its inhibitor KEAP1, allowing Nrf2 to translocate to the nucleus and activate the antioxidant response element (ARE) promoter sequences that drive expression of:

The net effect is a more robust capacity to conjugate and excrete toxic intermediates, whether endogenous (oxidized metabolic byproducts, hormones for excretion) or exogenous (environmental toxins, drug metabolites, dietary xenobiotics). This pattern of Phase II support without dramatic Phase I induction is characteristic of "supportive" detoxification herbs and distinguishes dandelion from agents like St. John's Wort that strongly induce Phase I cytochrome P450 3A4 (CYP3A4) and can cause clinically significant drug interactions. For the broader picture, see our Glutathione page.

Back to Table of Contents

The Traditional European Spring Liver Cleanse

The traditional European spring cleanse is one of the most enduring folk practices in Western herbal medicine, persisting from medieval times to the present day in many rural German, French, Italian, and Eastern European communities. The practice consists of consuming bitter spring greens — principally dandelion, but often combined with nettle, watercress, sorrel, chickweed, and other early-emerging wild plants — for several weeks in early spring as the snow recedes and the first wild greens become available.

The cleanse is timed by botanical calendar rather than by medical schedule. The signal is the emergence of young dandelion rosettes in the lawn, fence line, and woodland edge, typically late March through early May in temperate Europe. Young pre-flowering leaves are tender, mildly bitter, and at their nutritional peak, with maximum vitamin K, vitamin A precursors, vitamin C, calcium, iron, and the still-active bitter sesquiterpene lactones. The leaves become more bitter and tougher after the plant flowers, marking the natural end of the cleanse season.

Modern integrative interpretation of the practice maps reasonably well to physiologic plausibility:

Herbalists describe a modern adaptation of the practice as a 2-4 week spring "dandelion regimen": a daily dandelion-leaf salad (1-2 cups of fresh young leaves, dressed with olive oil and lemon), one cup of roasted dandelion-root tea per day, and a small daily glass of a bitter Italian aperitif or of homemade dandelion-leaf tincture diluted in water before the main meal. The effects people report over 2-4 weeks are better digestion after meals, modest weight loss (largely fluid), less dull skin and minor swelling (edema), and more energy.

Back to Table of Contents

The Milk Thistle Pairing for Fatty Liver

The most clinically important application of dandelion in modern integrative liver-support practice is the pairing with milk thistle (Silybum marianum). The two herbs are mechanistically complementary in a way that few herbal combinations can claim:

The pairing is foundational in integrative protocols for:

  1. Metabolic dysfunction-associated steatotic liver disease (MASLD, formerly non-alcoholic fatty liver disease) and its inflammatory form, MASH (formerly non-alcoholic steatohepatitis) — the most common chronic liver condition in the developed world
  2. Chronic mild transaminase elevation of unclear etiology, after the standard workup has excluded viral hepatitis, autoimmune hepatitis, hemochromatosis, alcoholic liver disease, and Wilson's disease
  3. Supportive care during medication-related liver stress — statins, methotrexate, isoniazid, anti-fungal azoles, certain chemotherapy agents
  4. Post-Amanita poisoning recovery — after the acute intravenous (IV) silibinin protocol, oral milk thistle and dandelion may be continued for weeks of recovery
  5. Recovery from alcohol-related liver injury after cessation of alcohol intake

The regimen integrative practitioners describe: standardized silymarin 200-400 mg three times daily, plus dandelion root tincture 2-5 mL three times daily, plus one cup of roasted dandelion root tea daily, for 8-12 weeks, with liver enzymes (serum transaminases) checked at baseline, 6 weeks, and 12 weeks. Practitioners report modest falls in mildly raised alanine aminotransferase (ALT) and aspartate aminotransferase (AST). See our Milk Thistle page for the silymarin side of the pairing in depth.

The pairing is also what the supplement market sells. A 2026 analysis of the 20 best-selling liver “cleanse” supplements at a large online retailer found that every one claimed to “eliminate toxins” or to “detox” or “cleanse” the liver, and 85% claimed to “enhance liver function.” Milk thistle was in 19 of the 20 products and dandelion in 13. The authors judged the scientific evidence for these ingredients' effect on liver health “limited and inconclusive.”

Back to Table of Contents

Fatty Liver Disease (MASLD) and Chronic Mild Transaminase Elevation

Metabolic dysfunction-associated steatotic liver disease (MASLD, formerly called non-alcoholic fatty liver disease or NAFLD) is now the most common chronic liver condition globally. A 2023 analysis of 92 population studies put its worldwide prevalence at about 30%, rising from 25.3% in 1990-2006 to 38.0% in 2016-2019; the figures were 31.2% for North America and 25.1% for Western Europe. It progresses through stages: simple steatosis (fat accumulation only), metabolic dysfunction-associated steatohepatitis (MASH, formerly non-alcoholic steatohepatitis or NASH, with inflammation and hepatocyte ballooning), fibrosis, cirrhosis, and ultimately a small fraction progress to hepatocellular carcinoma. The pathophysiology is closely linked to insulin resistance, metabolic syndrome, and visceral adiposity; the first-line management is weight loss, dietary modification (Mediterranean or low-carbohydrate patterns), exercise, and treatment of associated conditions like type 2 diabetes.

The new names date from 2023, when three large liver associations ran a consensus process with 236 experts from 56 countries; 61% and 66% of those responding felt the words “nonalcoholic” and “fatty” were stigmatising. The new diagnosis requires at least 1 of 5 heart-and-metabolic (cardiometabolic) risk factors, and people with MASLD who drink more alcohol each week (140-350 g for women, 210-420 g for men) are now grouped separately as MetALD.

Drug treatment was limited until the recent approval of resmetirom (a thyroid hormone receptor-beta agonist) for steatohepatitis with fibrosis. In 2025 the US Food and Drug Administration also gave accelerated approval to semaglutide (a glucagon-like peptide-1 receptor agonist) to treat MASH in adults with moderate-to-advanced fibrosis. The approval followed a phase 3 trial (ESSENCE): among the first 800 people with MASH and moderate or advanced scarring, weekly semaglutide 2.4 mg injections cleared the liver inflammation without worsening scarring in 62.9%, versus 34.3% on placebo, and reduced scarring in 36.8% versus 22.4%, after 72 weeks. Average weight loss was 10.5% versus 2.0%, and stomach and bowel side effects were more common with semaglutide. The FDA notes that the trial continues to 240 weeks to see whether these changes mean fewer deaths, transplants and other liver-related events. For most people with MASLD, management remains lifestyle-based, leaving room for adjunctive herbal support. Dandelion appears in many integrative protocols for fatty liver disease on the basis of:

For chronic mild transaminase elevation without an identified cause (after the standard workup), the integrative approach typically combines: dietary modification (reduced refined carbohydrate, reduced fructose, increased fiber, increased omega-3 fatty acids), the milk thistle + dandelion pairing discussed above, plus selective addition of berberine or alpha-lipoic acid where insulin resistance is present. Practitioners describe monthly liver-enzyme (transaminase) checks for the first 3 months, then every 6 months, to follow response and safety. See our Liver Disease page for the broader picture.

Back to Table of Contents

Dosage, Forms, and Preparation

For liver and detoxification applications, dandelion root is the preparation of choice (the leaf is preferred for diuretic applications). The root is harvested in autumn after the plant has stored carbohydrate and inulin for winter, washed, sliced, and dried. For tea preparations, the root is typically lightly roasted to develop a coffee-like aroma.

Treatment courses for hepatobiliary indications are typically 4-12 weeks. Integrative practitioners regard daily long-term use of moderate-dose dandelion-root tea (1-2 cups daily) as safe for healthy adults and as a long-term liver-support practice with low risk of adverse effects.

Back to Table of Contents

Cautions and Drug Interactions

Back to Table of Contents

Key Research Papers

  1. Blumenthal M et al. (eds.) (1998). The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council.
  2. European Medicines Agency. European Union herbal monograph on Taraxacum officinale Weber ex Wigg., radix cum herba (Dandelion Root with Herb). First published 28 January 2011, last updated 8 April 2020. — European Medicines Agency: Taraxaci radix cum herba
  3. Schutz K, Carle R, Schieber A (2006). Taraxacum — a review on its phytochemical and pharmacological profile. Journal of Ethnopharmacology. — PubMed PMID: 16950583
  4. You Y et al. (2010). In vitro and in vivo hepatoprotective effects of the aqueous extract from Taraxacum officinale root against alcohol-induced oxidative stress. Food and Chemical Toxicology. — PubMed PMID: 20347918
  5. Park CM, Park JY, Noh KH, Shin JH, Song YS (2011). Taraxacum officinale Weber extracts inhibit LPS-induced oxidative stress and nitric oxide production via the NF-kB modulation in RAW 264.7 cells. Journal of Ethnopharmacology. — PubMed PMID: 21075189
  6. Davaatseren M et al. (2013). Taraxacum official (dandelion) leaf extract alleviates high-fat diet-induced nonalcoholic fatty liver. Food and Chemical Toxicology. — PubMed PMID: 23603008
  7. Hu C, Kitts DD (2003). Antioxidant, prooxidant, and cytotoxic activities of solvent-fractionated dandelion (Taraxacum officinale) flower extracts in vitro. Journal of Agricultural and Food Chemistry. — PubMed PMID: 12502425
  8. Mahesh A, Jeyachandran R, Cindrella L, Thangadurai D, Veerapur VP, Muralidhara Rao D (2010). Hepatocurative potential of sesquiterpene lactones of Taraxacum officinale on carbon tetrachloride induced liver toxicity in mice. Acta Biologica Hungarica. 61(2):175-190. — PubMed PMID: 20519172
  9. Colle D et al. (2012). Antioxidant properties of Taraxacum officinale leaf extract are involved in the protective effect against hepatotoxicity induced by acetaminophen in mice. Journal of Medicinal Food. — PubMed PMID: 22424457
  10. Trojanova I, Rada V, Kokoska L, Vlkova E (2004). The bifidogenic effect of Taraxacum officinale root. Fitoterapia. — PubMed PMID: 15567259
  11. Wirngo FE, Lambert MN, Jeppesen PB (2016). The physiological effects of dandelion (Taraxacum officinale) in type 2 diabetes. Review of Diabetic Studies. — PubMed PMID: 28012278
  12. Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L (2023). The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 77(4):1335-1347. — PubMed PMID: 36626630
  13. Rinella ME, Lazarus JV, Ratziu V, et al.; NAFLD Nomenclature consensus group (2023). A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 78(6):1966-1986. — PubMed PMID: 37363821
  14. Sanyal AJ, Newsome PN, Kliers I, et al.; ESSENCE Study Group (2025). Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis. New England Journal of Medicine. 392(21):2089-2099. — PubMed PMID: 40305708
  15. U.S. Food and Drug Administration (2025). News release on the accelerated approval of semaglutide to treat metabolic-associated steatohepatitis (MASH) in adults with moderate-to-advanced fibrosis (content current as of 15 August 2025). — FDA: treatment for MASH
  16. Telbany A, Patel A, Viswanath P, Inga E, Paleti S (2026). Liver Cleansing Imposters: An Analysis of Popular Online Liver Supplements. American Journal of Gastroenterology. 121(1):171-178. — PubMed PMID: 40162684

PubMed Topic Searches

  1. PubMed: Taraxacum hepatoprotection
  2. PubMed: Cholagogue/choleretic
  3. PubMed: Dandelion / milk thistle
  4. PubMed: Dandelion / NAFLD
  5. PubMed: Taraxasterol hepatoprotection
  6. PubMed: Commission E monograph

Back to Table of Contents

Connections

Back to Table of Contents